The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement.

Gray stressed the effects are quite modest and only really effective at the really early stages of Alzheimer’s disease (and don’t work for vascular dementia ... as three months. The most commonly ...

Variations in the use of antidementia and antipsychotic drugs for nursing home residents with dementia across the United ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in ...

CADASIL is a brain disease involving genetic mutations, stroke, and dementia. Learn about symptom progression and ongoing ...

A BMJ investigation found seven of the eight doctors appointed by the US Food & Drug Administration (FDA) to review donanemab ...

Frontotemporal dementia hit headlines ... if it’s proven to be effective, will be very cheap to manufacture.” He said the fact multiple companies could produce the drug would also help ensure ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Researchers from DZNE and Otto von Guericke University Magdeburg have identified individuals with increased risk for dementia ...

The rate of antipsychotic drug use in nursing homes has remained stubbornly high. Experts are concerned about misuse.

Alzheimer’s disease is a devastating condition that mainly affects older adults, leading to severe memory loss, confusion, ...

Research shows that flavonoid-rich diets, including tea and red wine, are associated with a lower risk of dementia in ...